Nicholas Fidelman

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - lipidsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 28, 2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

|May 05, 2026
Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.

|Dec 19, 2023
Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.

Omar T Hassan, Spencer C Behr, Michael A Ohliger

|Dec 15, 2023
Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy.

Rana Rabei, Nicholas Fidelman

|May 27, 2021
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma.

Nadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen

|Nov 10, 2020
Outcomes of transjugular liver biopsies for liver transplant recipients with bicaval and piggyback hepatic vein anastomoses.

Adi Price, Adam Schwertner, David Tran

Pageof 2

Frequent Collaborators

2 joint publications

Farshid Dayyani

1 joint publications

Michael C Soulen

1 joint publications

Khashayar Farsad

1 joint publications

Ron C Gaba